Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
Sana Biotechnology sold approximately 21.6 million shares via its at-the-market (ATM) facility, generating about $69 million in net proceeds. Combined with a recent $25 million investment from the Mayo Clinic, the total capital raised since Q1 2026 is approximately $94 million, extending the company's expected cash runway to mid-2027. These proceed…